Predictors of Recurrence in Human Papillomavirus‐Associated Oropharyngeal Squamous Cell Carcinoma
Otolaryngology–Head and Neck Surgery · 2026-07 · 175 (1) · 126-135
DOI: 10.1002/ohn.70237 ↗Kurz gefasst
Fachartikel in der Zeitschrift Otolaryngology–Head and Neck Surgery, online erschienen am 14.04.2026. Verfasst von Ella P Jackert und 8 weiteren Autor:innen. Beteiligte Einrichtung: Keck School of Medicine of the University of Southern California, Los Angeles, California, USA. Hauptthemen laut MEDLINE: Neoplasm Recurrence, Local, Oropharyngeal Neoplasms, Papillomavirus Infections, Human Papillomavirus Viruses. Die Arbeit nennt 39 Literaturangaben.
Abstract (Originalsprache)
Objective
Despite improved survival for patients with HPV‐associated oropharyngeal squamous cell carcinoma (HPV+ OPSCC), up to 30% of cancers recur. This study elucidates independent predictors of recurrence and survival in HPV+ OPSCC patients. Study design Retrospective cohort study.
Setting
Academic tertiary care center.
Methods
Patients diagnosed with HPV+OPSCC from 2014 to 2024 were included. Electronic health records were manually searched for demographic, oncologic, treatment, and outcomes data. The primary outcome was recurrence within 5‐years of completion of primary treatment. The secondary outcome was 5‐year survival. Kaplan‐Meier and log‐rank tests were performed for univariate analyses. Cox regression analysis identified independent predictors of recurrence and mortality.
Results
Of the 239 patients included, 61 (25.5%) experienced recurrence within 5 years after completion of definitive treatment. Of recurrent cases, over one‐third involved distant metastases, predominantly to the lung, with a subset involving atypical sites such as bone, liver, and skull base. On multivariable Cox regression analysis, perineural invasion was independently associated with any recurrence (HR: 2.440, 95% CI: 1.330, 4.477) and distant metastatic recurrence (HR: 3.107, 95% CI: 1.097, 8.794). The overlapping oropharynx tumor subsite was significantly associated with mortality (HR: 2.102, 95% CI: 1.053, 4.198).
Conclusion
Our results highlight distinct patterns of recurrence and survival which support the consideration of more individualized surveillance approaches, especially in HPV+ OPSCC patients with perineural invasion.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Keck School of Medicine of the University of Southern California, Los Angeles, California, USA.
- USC Caruso Department of Otolaryngology Head and Neck Surgery, Los Angeles, California, USA.
- Western University of Health Sciences, Pomona, California, USA.
ORCID-Profile: Albert Y Han
Zitieren
APA
Jackert, E. P., Wong, S., Shen, K., Zalin, M., Tang, L., Kwon, D., Kokot, N., Sinha, U., & Han, A. Y. (2026). Predictors of Recurrence in Human Papillomavirus‐Associated Oropharyngeal Squamous Cell Carcinoma. Otolaryngology–Head and Neck Surgery, 175(1), 126-135. https://doi.org/10.1002/ohn.70237
Vancouver
Jackert EP, Wong S, Shen K, Zalin M, Tang L, Kwon D, et al. Predictors of Recurrence in Human Papillomavirus‐Associated Oropharyngeal Squamous Cell Carcinoma. Otolaryngology–Head and Neck Surgery. 2026;175(1):126-135. doi:10.1002/ohn.70237
BibTeX
@article{Jackert2026,
author = {Jackert, Ella P and Wong, Stephanie and Shen, Katie and Zalin, Michael and Tang, Liyang and Kwon, Daniel and Kokot, Niels and Sinha, Uttam and Han, Albert Y},
title = {Predictors of Recurrence in Human Papillomavirus‐Associated Oropharyngeal Squamous Cell Carcinoma},
journal = {Otolaryngology–Head and Neck Surgery},
year = {2026},
volume = {175},
number = {1},
pages = {126--135},
doi = {10.1002/ohn.70237}
}
EUVIMED